Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Vasospasm, Intracranial | 20 | 2024 | 215 | 5.970 |
Why?
|
Stroke | 95 | 2024 | 9962 | 5.770 |
Why?
|
Brain Ischemia | 50 | 2023 | 3127 | 4.550 |
Why?
|
Cerebrovascular Disorders | 13 | 2023 | 1501 | 3.990 |
Why?
|
Vasoconstriction | 19 | 2023 | 593 | 3.510 |
Why?
|
Cerebral Angiography | 23 | 2021 | 1274 | 2.480 |
Why?
|
Vasculitis, Central Nervous System | 8 | 2022 | 45 | 2.280 |
Why?
|
Posterior Leukoencephalopathy Syndrome | 4 | 2023 | 50 | 2.000 |
Why?
|
Ischemic Attack, Transient | 10 | 2022 | 901 | 1.990 |
Why?
|
Headache Disorders, Primary | 7 | 2021 | 39 | 1.970 |
Why?
|
Intracranial Arteriosclerosis | 5 | 2022 | 137 | 1.910 |
Why?
|
Cerebral Arterial Diseases | 5 | 2017 | 82 | 1.880 |
Why?
|
Cerebral Infarction | 7 | 2020 | 982 | 1.520 |
Why?
|
Oxygen Inhalation Therapy | 9 | 2016 | 404 | 1.470 |
Why?
|
Thrombectomy | 7 | 2024 | 708 | 1.340 |
Why?
|
Cerebral Hemorrhage | 12 | 2020 | 2660 | 1.280 |
Why?
|
Cerebral Arteries | 9 | 2013 | 493 | 1.250 |
Why?
|
Puerperal Disorders | 4 | 2019 | 300 | 1.210 |
Why?
|
Subarachnoid Hemorrhage | 9 | 2024 | 1032 | 1.130 |
Why?
|
Intracranial Arterial Diseases | 3 | 2019 | 22 | 1.120 |
Why?
|
Muscle Weakness | 2 | 2020 | 413 | 1.070 |
Why?
|
Paresis | 3 | 2021 | 177 | 1.010 |
Why?
|
Cerebrovascular Circulation | 11 | 2020 | 2733 | 0.990 |
Why?
|
Diffusion Magnetic Resonance Imaging | 16 | 2021 | 2782 | 0.920 |
Why?
|
Hyperbaric Oxygenation | 4 | 2008 | 166 | 0.840 |
Why?
|
Nervous System Diseases | 5 | 2022 | 1647 | 0.820 |
Why?
|
Endocarditis | 3 | 2021 | 351 | 0.790 |
Why?
|
Glycyrrhiza | 2 | 2011 | 9 | 0.760 |
Why?
|
Severity of Illness Index | 18 | 2024 | 15840 | 0.760 |
Why?
|
Neuroprotective Agents | 4 | 2019 | 961 | 0.750 |
Why?
|
Takayasu Arteritis | 1 | 2022 | 95 | 0.730 |
Why?
|
Headache | 9 | 2024 | 1249 | 0.720 |
Why?
|
Intracranial Hemorrhages | 5 | 2021 | 844 | 0.690 |
Why?
|
Hematoma, Subdural | 1 | 2020 | 126 | 0.670 |
Why?
|
Venous Thrombosis | 4 | 2024 | 1299 | 0.630 |
Why?
|
Brain Diseases | 7 | 2021 | 1540 | 0.620 |
Why?
|
Heparin | 3 | 2021 | 1652 | 0.610 |
Why?
|
Endovascular Procedures | 7 | 2024 | 2165 | 0.610 |
Why?
|
Infarction, Middle Cerebral Artery | 8 | 2021 | 485 | 0.610 |
Why?
|
Humans | 182 | 2024 | 760621 | 0.590 |
Why?
|
Brain | 32 | 2024 | 26951 | 0.590 |
Why?
|
Female | 124 | 2024 | 391270 | 0.590 |
Why?
|
Recurrence | 8 | 2023 | 8482 | 0.580 |
Why?
|
Magnetic Resonance Imaging | 41 | 2024 | 36290 | 0.570 |
Why?
|
Middle Aged | 89 | 2024 | 220352 | 0.560 |
Why?
|
Registries | 7 | 2018 | 8469 | 0.550 |
Why?
|
Propensity Score | 1 | 2024 | 1928 | 0.550 |
Why?
|
Male | 121 | 2024 | 359744 | 0.540 |
Why?
|
Metformin | 1 | 2024 | 912 | 0.540 |
Why?
|
Hyperoxia | 5 | 2005 | 250 | 0.540 |
Why?
|
Pregnancy Complications, Cardiovascular | 1 | 2021 | 516 | 0.540 |
Why?
|
Brain Edema | 7 | 2016 | 603 | 0.520 |
Why?
|
Coma | 7 | 2024 | 487 | 0.520 |
Why?
|
Vasomotor System | 1 | 2016 | 207 | 0.510 |
Why?
|
Moyamoya Disease | 1 | 2019 | 255 | 0.510 |
Why?
|
Tomography, X-Ray Computed | 22 | 2024 | 20509 | 0.510 |
Why?
|
Brain Infarction | 8 | 2023 | 292 | 0.510 |
Why?
|
Emergencies | 1 | 2022 | 1211 | 0.500 |
Why?
|
Eclampsia | 2 | 2021 | 56 | 0.500 |
Why?
|
Migraine Disorders | 3 | 2017 | 1693 | 0.480 |
Why?
|
Tissue Plasminogen Activator | 8 | 2016 | 1190 | 0.470 |
Why?
|
Anticoagulants | 7 | 2023 | 4897 | 0.470 |
Why?
|
International Cooperation | 4 | 2018 | 1433 | 0.470 |
Why?
|
Recovery of Function | 9 | 2021 | 2985 | 0.470 |
Why?
|
Hypoglycemic Agents | 3 | 2024 | 3150 | 0.460 |
Why?
|
Renal Artery Obstruction | 1 | 2015 | 224 | 0.460 |
Why?
|
Intracranial Thrombosis | 3 | 2024 | 109 | 0.460 |
Why?
|
Aged | 76 | 2024 | 169152 | 0.460 |
Why?
|
Muscle Strength | 1 | 2018 | 619 | 0.450 |
Why?
|
Quality of Health Care | 4 | 2018 | 4360 | 0.450 |
Why?
|
Cerebral Veins | 3 | 2017 | 157 | 0.450 |
Why?
|
Pregnancy Complications | 3 | 2019 | 2942 | 0.440 |
Why?
|
Foramen Ovale, Patent | 2 | 2013 | 214 | 0.430 |
Why?
|
Carotid Stenosis | 4 | 2018 | 878 | 0.430 |
Why?
|
Syndrome | 8 | 2024 | 3280 | 0.430 |
Why?
|
Acute Disease | 20 | 2024 | 7269 | 0.430 |
Why?
|
Diagnosis, Differential | 16 | 2024 | 12965 | 0.430 |
Why?
|
Unemployment | 1 | 2014 | 209 | 0.420 |
Why?
|
Atrial Fibrillation | 5 | 2023 | 5209 | 0.420 |
Why?
|
Thrombolytic Therapy | 8 | 2021 | 2108 | 0.410 |
Why?
|
India | 6 | 2019 | 2336 | 0.410 |
Why?
|
Aged, 80 and over | 40 | 2024 | 58995 | 0.400 |
Why?
|
Treatment Outcome | 32 | 2024 | 65017 | 0.390 |
Why?
|
Motor Cortex | 3 | 2018 | 995 | 0.390 |
Why?
|
Endarterectomy, Carotid | 2 | 2007 | 564 | 0.390 |
Why?
|
Retrospective Studies | 36 | 2024 | 80372 | 0.380 |
Why?
|
Constriction, Pathologic | 2 | 2013 | 1098 | 0.370 |
Why?
|
Adult | 60 | 2022 | 219994 | 0.360 |
Why?
|
Risk Factors | 26 | 2023 | 74359 | 0.360 |
Why?
|
Thromboembolism | 3 | 2013 | 1017 | 0.350 |
Why?
|
Arterial Occlusive Diseases | 3 | 2023 | 752 | 0.340 |
Why?
|
Carotid Artery, External | 1 | 2009 | 38 | 0.340 |
Why?
|
Carotid Artery, Internal, Dissection | 1 | 2009 | 42 | 0.330 |
Why?
|
Vascular System Injuries | 2 | 2023 | 247 | 0.330 |
Why?
|
Neurosurgical Procedures | 1 | 2020 | 2056 | 0.330 |
Why?
|
Oxygen | 8 | 2023 | 4193 | 0.310 |
Why?
|
Eligibility Determination | 1 | 2011 | 421 | 0.300 |
Why?
|
Frontal Lobe | 3 | 2018 | 1420 | 0.290 |
Why?
|
Reperfusion | 4 | 2010 | 271 | 0.280 |
Why?
|
Glucocorticoids | 1 | 2016 | 2145 | 0.280 |
Why?
|
Tomography Scanners, X-Ray Computed | 3 | 2014 | 172 | 0.280 |
Why?
|
Patient Selection | 4 | 2020 | 4283 | 0.280 |
Why?
|
Middle Cerebral Artery | 5 | 2020 | 276 | 0.280 |
Why?
|
Blast Crisis | 1 | 2007 | 101 | 0.280 |
Why?
|
Prognosis | 22 | 2022 | 29658 | 0.270 |
Why?
|
Collateral Circulation | 2 | 2021 | 292 | 0.260 |
Why?
|
Disease Progression | 12 | 2021 | 13502 | 0.260 |
Why?
|
Vascular Diseases | 2 | 2005 | 1182 | 0.260 |
Why?
|
Postpartum Period | 2 | 2021 | 1167 | 0.250 |
Why?
|
Guillain-Barre Syndrome | 2 | 2005 | 125 | 0.250 |
Why?
|
Electrocardiography, Ambulatory | 2 | 2022 | 578 | 0.250 |
Why?
|
Hypothermia, Induced | 2 | 2008 | 758 | 0.250 |
Why?
|
Psychotic Disorders | 1 | 2020 | 3193 | 0.250 |
Why?
|
Spinal Puncture | 1 | 2007 | 281 | 0.250 |
Why?
|
Image Processing, Computer-Assisted | 4 | 2016 | 8950 | 0.240 |
Why?
|
Intracranial Embolism | 4 | 2020 | 192 | 0.240 |
Why?
|
Pre-Eclampsia | 2 | 2021 | 1229 | 0.240 |
Why?
|
Wakefulness | 2 | 2010 | 1255 | 0.240 |
Why?
|
Time Factors | 13 | 2022 | 40165 | 0.240 |
Why?
|
Hypoxia-Ischemia, Brain | 2 | 2012 | 352 | 0.230 |
Why?
|
Disability Evaluation | 3 | 2021 | 1826 | 0.230 |
Why?
|
Ultrasonography, Doppler, Transcranial | 4 | 2020 | 281 | 0.230 |
Why?
|
Leukemia, Myeloid | 1 | 2007 | 695 | 0.230 |
Why?
|
Predictive Value of Tests | 15 | 2020 | 15289 | 0.220 |
Why?
|
Warfarin | 3 | 2021 | 1518 | 0.220 |
Why?
|
Bartonella Infections | 1 | 2003 | 21 | 0.220 |
Why?
|
Thrombosis | 3 | 2021 | 3052 | 0.220 |
Why?
|
Muscle, Skeletal | 1 | 2018 | 4925 | 0.220 |
Why?
|
Magnetic Resonance Angiography | 6 | 2024 | 1431 | 0.210 |
Why?
|
Dementia, Vascular | 1 | 2004 | 123 | 0.210 |
Why?
|
Pyramidal Tracts | 2 | 2015 | 250 | 0.210 |
Why?
|
Upper Extremity | 3 | 2018 | 661 | 0.210 |
Why?
|
Sinus Thrombosis, Intracranial | 1 | 2024 | 110 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3085 | 0.210 |
Why?
|
Prospective Studies | 20 | 2023 | 54303 | 0.210 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3205 | 0.210 |
Why?
|
Takotsubo Cardiomyopathy | 1 | 2024 | 124 | 0.200 |
Why?
|
Carotid Artery Diseases | 3 | 2010 | 883 | 0.200 |
Why?
|
Heart Arrest | 5 | 2012 | 1506 | 0.200 |
Why?
|
Seizures | 3 | 2010 | 2917 | 0.190 |
Why?
|
Young Adult | 18 | 2020 | 58741 | 0.190 |
Why?
|
Hypoxia, Brain | 1 | 2002 | 138 | 0.190 |
Why?
|
Thiazoles | 2 | 2021 | 1511 | 0.190 |
Why?
|
Reflex | 1 | 2003 | 376 | 0.190 |
Why?
|
Serotonin Receptor Agonists | 1 | 2002 | 151 | 0.190 |
Why?
|
Mental Disorders | 1 | 2021 | 6796 | 0.180 |
Why?
|
Embolism, Paradoxical | 1 | 2021 | 55 | 0.180 |
Why?
|
Cross-Over Studies | 2 | 2017 | 2061 | 0.180 |
Why?
|
Clinical Trials as Topic | 4 | 2014 | 8056 | 0.180 |
Why?
|
Hyperglycemia | 2 | 2009 | 1380 | 0.180 |
Why?
|
Chickenpox | 1 | 2001 | 97 | 0.180 |
Why?
|
Clinical Protocols | 2 | 2018 | 1440 | 0.180 |
Why?
|
Sagittal Sinus Thrombosis | 1 | 1999 | 11 | 0.180 |
Why?
|
Pregnancy | 6 | 2021 | 29749 | 0.170 |
Why?
|
Patient Transfer | 2 | 2020 | 779 | 0.170 |
Why?
|
Liver Cirrhosis, Alcoholic | 1 | 1999 | 64 | 0.170 |
Why?
|
Immunologic Factors | 2 | 2020 | 1588 | 0.170 |
Why?
|
Ankle Joint | 1 | 2003 | 435 | 0.160 |
Why?
|
Confusion | 1 | 2021 | 279 | 0.160 |
Why?
|
Encephalitis | 1 | 2003 | 437 | 0.160 |
Why?
|
Delusions | 1 | 2021 | 298 | 0.160 |
Why?
|
Long QT Syndrome | 1 | 2023 | 466 | 0.160 |
Why?
|
After-Hours Care | 1 | 2020 | 102 | 0.160 |
Why?
|
Quadriplegia | 2 | 2003 | 226 | 0.160 |
Why?
|
Heart Neoplasms | 1 | 2022 | 360 | 0.160 |
Why?
|
Sleep | 2 | 2020 | 4751 | 0.160 |
Why?
|
Social Planning | 1 | 2018 | 9 | 0.150 |
Why?
|
Drug Administration Routes | 2 | 2016 | 150 | 0.150 |
Why?
|
Hypertension | 6 | 2020 | 8594 | 0.150 |
Why?
|
Rupture, Spontaneous | 1 | 2018 | 356 | 0.150 |
Why?
|
China | 3 | 2018 | 2339 | 0.140 |
Why?
|
Leukoaraiosis | 2 | 2009 | 116 | 0.140 |
Why?
|
Carotid Artery Injuries | 1 | 1998 | 96 | 0.140 |
Why?
|
Status Epilepticus | 1 | 2003 | 456 | 0.140 |
Why?
|
Pyridines | 3 | 2021 | 2879 | 0.140 |
Why?
|
Adolescent | 19 | 2020 | 87810 | 0.140 |
Why?
|
Hemoglobinuria, Paroxysmal | 1 | 2017 | 95 | 0.140 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2007 | 3765 | 0.140 |
Why?
|
Causality | 5 | 2011 | 1242 | 0.140 |
Why?
|
Fatal Outcome | 3 | 2009 | 1832 | 0.140 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2018 | 361 | 0.130 |
Why?
|
Motor Activity | 3 | 2018 | 2687 | 0.130 |
Why?
|
Natural Language Processing | 1 | 2024 | 1135 | 0.130 |
Why?
|
Fibrinolytic Agents | 3 | 2016 | 2167 | 0.130 |
Why?
|
Cohort Studies | 12 | 2018 | 41335 | 0.130 |
Why?
|
Neuronal Plasticity | 4 | 2013 | 1430 | 0.130 |
Why?
|
Functional Laterality | 4 | 2012 | 2253 | 0.130 |
Why?
|
Methylprednisolone | 1 | 2016 | 384 | 0.120 |
Why?
|
Logistic Models | 6 | 2023 | 13314 | 0.120 |
Why?
|
Perfusion | 2 | 2012 | 1376 | 0.120 |
Why?
|
Critical Pathways | 1 | 2019 | 475 | 0.120 |
Why?
|
Regression Analysis | 5 | 2016 | 6360 | 0.120 |
Why?
|
Hypertension, Pregnancy-Induced | 1 | 2021 | 518 | 0.120 |
Why?
|
Diabetes Complications | 2 | 2020 | 1341 | 0.120 |
Why?
|
Embolism | 1 | 2018 | 408 | 0.120 |
Why?
|
Rats | 13 | 2013 | 23711 | 0.120 |
Why?
|
Comorbidity | 6 | 2017 | 10551 | 0.120 |
Why?
|
Antifungal Agents | 1 | 2019 | 749 | 0.120 |
Why?
|
Vertebral Artery | 1 | 1995 | 185 | 0.120 |
Why?
|
Leukocyte Count | 1 | 2018 | 1600 | 0.120 |
Why?
|
Heart Valve Diseases | 1 | 2022 | 1047 | 0.120 |
Why?
|
Movement | 2 | 2014 | 1474 | 0.120 |
Why?
|
Blood Volume | 2 | 2012 | 550 | 0.110 |
Why?
|
Patient Admission | 2 | 2020 | 1386 | 0.110 |
Why?
|
Rats, Sprague-Dawley | 9 | 2018 | 8158 | 0.110 |
Why?
|
Glyburide | 1 | 2014 | 114 | 0.110 |
Why?
|
Risk Assessment | 8 | 2020 | 24123 | 0.110 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2006 | 3334 | 0.110 |
Why?
|
Mandible | 1 | 1998 | 750 | 0.110 |
Why?
|
Case-Control Studies | 5 | 2020 | 22053 | 0.110 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2021 | 936 | 0.110 |
Why?
|
Vision Disorders | 4 | 2017 | 1084 | 0.100 |
Why?
|
Hospital Mortality | 4 | 2021 | 5425 | 0.100 |
Why?
|
Matrix Metalloproteinase 9 | 2 | 2014 | 632 | 0.100 |
Why?
|
Intracranial Aneurysm | 1 | 2002 | 1276 | 0.100 |
Why?
|
Osteotomy | 1 | 1998 | 836 | 0.100 |
Why?
|
Arteriovenous Malformations | 1 | 1995 | 397 | 0.100 |
Why?
|
Managed Care Programs | 1 | 2018 | 939 | 0.100 |
Why?
|
Cesarean Section | 1 | 2021 | 1385 | 0.100 |
Why?
|
Aspirin | 2 | 2022 | 3364 | 0.100 |
Why?
|
Emergency Service, Hospital | 3 | 2022 | 7818 | 0.100 |
Why?
|
Basilar Artery | 2 | 2012 | 205 | 0.100 |
Why?
|
Hematologic Tests | 1 | 2013 | 238 | 0.100 |
Why?
|
Rats, Wistar | 2 | 2012 | 1850 | 0.100 |
Why?
|
Hospitals | 3 | 2019 | 3928 | 0.090 |
Why?
|
Blood Gas Analysis | 1 | 2012 | 379 | 0.090 |
Why?
|
Nimodipine | 1 | 2010 | 56 | 0.090 |
Why?
|
Statistics, Nonparametric | 1 | 2016 | 2852 | 0.090 |
Why?
|
Disease Management | 2 | 2019 | 2514 | 0.090 |
Why?
|
Drug Administration Schedule | 1 | 2019 | 4899 | 0.090 |
Why?
|
Physician's Role | 1 | 2017 | 918 | 0.090 |
Why?
|
Secondary Prevention | 2 | 2016 | 1548 | 0.090 |
Why?
|
Pandemics | 2 | 2021 | 8624 | 0.090 |
Why?
|
Telemedicine | 2 | 2021 | 3018 | 0.090 |
Why?
|
Heart Rate | 1 | 2022 | 4179 | 0.090 |
Why?
|
Verapamil | 1 | 2010 | 242 | 0.090 |
Why?
|
Multivariate Analysis | 4 | 2014 | 12159 | 0.090 |
Why?
|
Gravitation | 1 | 2009 | 82 | 0.080 |
Why?
|
Neurology | 1 | 2017 | 779 | 0.080 |
Why?
|
Electronic Health Records | 2 | 2024 | 4775 | 0.080 |
Why?
|
Administration, Oral | 2 | 2023 | 4035 | 0.080 |
Why?
|
Triage | 1 | 2016 | 987 | 0.080 |
Why?
|
Vasoconstrictor Agents | 2 | 2004 | 651 | 0.080 |
Why?
|
Prevalence | 5 | 2018 | 15687 | 0.080 |
Why?
|
Databases, Factual | 3 | 2020 | 8035 | 0.080 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2019 | 1582 | 0.080 |
Why?
|
Aphasia | 1 | 2010 | 192 | 0.080 |
Why?
|
Cardiomyopathies | 1 | 2021 | 1952 | 0.080 |
Why?
|
Critical Care | 2 | 2020 | 2699 | 0.080 |
Why?
|
Robotics | 2 | 2013 | 874 | 0.080 |
Why?
|
Heparin, Low-Molecular-Weight | 2 | 2021 | 345 | 0.080 |
Why?
|
Contraceptives, Oral, Hormonal | 1 | 2010 | 190 | 0.080 |
Why?
|
Hemodynamics | 3 | 2020 | 4174 | 0.080 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2021 | 3201 | 0.070 |
Why?
|
Carotid Artery, Internal | 1 | 2010 | 438 | 0.070 |
Why?
|
Diffusion Tensor Imaging | 2 | 2015 | 2385 | 0.070 |
Why?
|
Vertebrobasilar Insufficiency | 1 | 2008 | 112 | 0.070 |
Why?
|
Iodine | 1 | 2009 | 286 | 0.070 |
Why?
|
Mortality | 2 | 2016 | 2916 | 0.070 |
Why?
|
Disease Models, Animal | 8 | 2018 | 18137 | 0.070 |
Why?
|
Disease-Free Survival | 1 | 2017 | 6828 | 0.070 |
Why?
|
Spinal Cord | 1 | 1995 | 1817 | 0.070 |
Why?
|
Arteries | 2 | 2022 | 1126 | 0.070 |
Why?
|
Vasculitis | 1 | 2011 | 523 | 0.070 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2014 | 1131 | 0.070 |
Why?
|
Pilot Projects | 3 | 2014 | 8555 | 0.070 |
Why?
|
Double-Blind Method | 5 | 2021 | 12427 | 0.070 |
Why?
|
Analysis of Variance | 3 | 2010 | 6238 | 0.070 |
Why?
|
Plaque, Atherosclerotic | 1 | 2018 | 1518 | 0.070 |
Why?
|
United States | 7 | 2022 | 72461 | 0.070 |
Why?
|
International Normalized Ratio | 1 | 2008 | 386 | 0.070 |
Why?
|
Anatomy, Artistic | 1 | 2006 | 51 | 0.070 |
Why?
|
Follow-Up Studies | 6 | 2016 | 39261 | 0.070 |
Why?
|
Animals | 18 | 2018 | 167963 | 0.070 |
Why?
|
Sex Factors | 2 | 2019 | 10547 | 0.070 |
Why?
|
Telencephalon | 1 | 2007 | 142 | 0.070 |
Why?
|
Diabetic Angiopathies | 1 | 2011 | 822 | 0.070 |
Why?
|
Vasodilator Agents | 1 | 2010 | 978 | 0.070 |
Why?
|
Haloperidol | 1 | 1988 | 389 | 0.070 |
Why?
|
Energy Metabolism | 2 | 2007 | 2869 | 0.070 |
Why?
|
Medical Illustration | 1 | 2006 | 135 | 0.060 |
Why?
|
Education, Medical | 1 | 2017 | 1727 | 0.060 |
Why?
|
Leukocytosis | 1 | 2007 | 251 | 0.060 |
Why?
|
Nitric Oxide Donors | 1 | 2006 | 125 | 0.060 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2015 | 3340 | 0.060 |
Why?
|
Dilatation, Pathologic | 1 | 2007 | 527 | 0.060 |
Why?
|
Blood-Brain Barrier | 2 | 2002 | 1019 | 0.060 |
Why?
|
Diagnosis, Computer-Assisted | 2 | 2007 | 707 | 0.060 |
Why?
|
Odds Ratio | 5 | 2021 | 9716 | 0.060 |
Why?
|
Heart Diseases | 1 | 2018 | 2809 | 0.060 |
Why?
|
Thrombocytopenia | 2 | 2017 | 1174 | 0.060 |
Why?
|
Accident Proneness | 1 | 2004 | 4 | 0.060 |
Why?
|
Aspartic Acid | 1 | 2007 | 576 | 0.060 |
Why?
|
Chronic Disease | 2 | 2017 | 9287 | 0.060 |
Why?
|
Immunosuppressive Agents | 2 | 2014 | 4166 | 0.060 |
Why?
|
Survival Rate | 2 | 2017 | 12808 | 0.060 |
Why?
|
Neurocysticercosis | 1 | 2006 | 91 | 0.060 |
Why?
|
Emergency Medical Services | 1 | 2016 | 1925 | 0.060 |
Why?
|
Models, Animal | 2 | 2011 | 2117 | 0.060 |
Why?
|
Adenocarcinoma | 1 | 2002 | 6315 | 0.060 |
Why?
|
Angiography | 1 | 2009 | 1605 | 0.060 |
Why?
|
Decision Support Techniques | 1 | 2014 | 2001 | 0.060 |
Why?
|
Inpatients | 1 | 2015 | 2581 | 0.060 |
Why?
|
Intracranial Pressure | 1 | 2006 | 325 | 0.060 |
Why?
|
Cranial Sinuses | 1 | 2024 | 68 | 0.060 |
Why?
|
Head | 1 | 2009 | 922 | 0.060 |
Why?
|
Anti-Bacterial Agents | 2 | 2019 | 7408 | 0.060 |
Why?
|
Laser-Doppler Flowmetry | 3 | 2011 | 239 | 0.060 |
Why?
|
Colitis, Ulcerative | 1 | 1995 | 1919 | 0.050 |
Why?
|
Patient Care Planning | 1 | 2008 | 908 | 0.050 |
Why?
|
Crohn Disease | 1 | 1995 | 2275 | 0.050 |
Why?
|
Blood Glucose | 2 | 2009 | 6381 | 0.050 |
Why?
|
Hydrocortisone | 1 | 2010 | 1803 | 0.050 |
Why?
|
Observer Variation | 4 | 2012 | 2601 | 0.050 |
Why?
|
Calcium Channel Blockers | 1 | 2006 | 694 | 0.050 |
Why?
|
Protein Denaturation | 1 | 2002 | 242 | 0.050 |
Why?
|
Lactic Acid | 1 | 2007 | 1134 | 0.050 |
Why?
|
Corpus Callosum | 1 | 2007 | 749 | 0.050 |
Why?
|
Cerebral Cortex | 3 | 2011 | 5761 | 0.050 |
Why?
|
Ephedrine | 1 | 2002 | 52 | 0.050 |
Why?
|
Heme Oxygenase (Decyclizing) | 1 | 2002 | 167 | 0.050 |
Why?
|
Review Literature as Topic | 1 | 2004 | 349 | 0.050 |
Why?
|
Lung | 1 | 2020 | 9994 | 0.050 |
Why?
|
Schizophrenia | 1 | 2020 | 6915 | 0.050 |
Why?
|
Infarction | 1 | 2023 | 248 | 0.050 |
Why?
|
Regional Blood Flow | 1 | 2005 | 1490 | 0.050 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2006 | 2282 | 0.050 |
Why?
|
Patient Readmission | 1 | 2015 | 3323 | 0.050 |
Why?
|
Hospitalization | 2 | 2018 | 10790 | 0.050 |
Why?
|
Huntington Disease | 1 | 1988 | 1141 | 0.050 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2023 | 629 | 0.050 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2005 | 664 | 0.040 |
Why?
|
Infusions, Intravenous | 3 | 2014 | 2234 | 0.040 |
Why?
|
Craniotomy | 1 | 2004 | 741 | 0.040 |
Why?
|
Inflammation | 1 | 2020 | 10756 | 0.040 |
Why?
|
Brain Injuries | 2 | 2002 | 2044 | 0.040 |
Why?
|
Age Distribution | 4 | 2011 | 2893 | 0.040 |
Why?
|
Heme Oxygenase-1 | 1 | 2002 | 364 | 0.040 |
Why?
|
Hippocampus | 1 | 2012 | 3738 | 0.040 |
Why?
|
Cerebellum | 3 | 2013 | 1496 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2016 | 10344 | 0.040 |
Why?
|
Contrast Sensitivity | 1 | 2001 | 235 | 0.040 |
Why?
|
Data Mining | 1 | 2024 | 553 | 0.040 |
Why?
|
Electrocardiography | 1 | 2013 | 6414 | 0.040 |
Why?
|
Hemorrhage | 2 | 2021 | 3600 | 0.040 |
Why?
|
Diabetes Mellitus | 1 | 2017 | 5889 | 0.040 |
Why?
|
American Heart Association | 1 | 2024 | 1081 | 0.040 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2006 | 1523 | 0.040 |
Why?
|
Movement Disorders | 2 | 2015 | 459 | 0.040 |
Why?
|
Sensitivity and Specificity | 5 | 2016 | 14660 | 0.040 |
Why?
|
Kidney Diseases | 1 | 2009 | 2093 | 0.040 |
Why?
|
Quality of Life | 2 | 2023 | 13308 | 0.040 |
Why?
|
Glycopeptides | 1 | 2000 | 220 | 0.040 |
Why?
|
Phlebography | 1 | 1999 | 325 | 0.040 |
Why?
|
Troponin T | 1 | 2023 | 774 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2023 | 1722 | 0.040 |
Why?
|
Length of Stay | 2 | 2018 | 6479 | 0.040 |
Why?
|
Carotid Artery Thrombosis | 1 | 1998 | 51 | 0.040 |
Why?
|
Prognathism | 1 | 1998 | 26 | 0.040 |
Why?
|
Intracranial Embolism and Thrombosis | 1 | 1998 | 144 | 0.040 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2023 | 854 | 0.040 |
Why?
|
New England | 1 | 2021 | 1050 | 0.040 |
Why?
|
Recombinant Proteins | 2 | 2013 | 6538 | 0.040 |
Why?
|
Asia, Western | 1 | 2017 | 19 | 0.040 |
Why?
|
Bone Marrow Examination | 1 | 2017 | 155 | 0.040 |
Why?
|
Heart Atria | 1 | 2023 | 1346 | 0.040 |
Why?
|
Diagnostic Imaging | 2 | 2011 | 3527 | 0.040 |
Why?
|
Disseminated Intravascular Coagulation | 1 | 2017 | 187 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2002 | 1246 | 0.040 |
Why?
|
Anemia, Hemolytic | 1 | 2017 | 163 | 0.030 |
Why?
|
Poisoning | 1 | 1998 | 252 | 0.030 |
Why?
|
Gene Targeting | 1 | 2000 | 839 | 0.030 |
Why?
|
PubMed | 1 | 2017 | 128 | 0.030 |
Why?
|
Blood Coagulation Disorders | 1 | 1999 | 349 | 0.030 |
Why?
|
Ischemia | 1 | 2005 | 1893 | 0.030 |
Why?
|
Massachusetts | 2 | 2024 | 8803 | 0.030 |
Why?
|
Aminosalicylic Acids | 1 | 1995 | 37 | 0.030 |
Why?
|
Echocardiography, Transesophageal | 1 | 2002 | 1108 | 0.030 |
Why?
|
Corpus Striatum | 1 | 2002 | 1233 | 0.030 |
Why?
|
Child | 6 | 2011 | 79806 | 0.030 |
Why?
|
Lipoxygenase Inhibitors | 1 | 1995 | 93 | 0.030 |
Why?
|
Sex Distribution | 3 | 2011 | 2295 | 0.030 |
Why?
|
Central Nervous System | 1 | 2022 | 1334 | 0.030 |
Why?
|
Treatment Failure | 1 | 2021 | 2648 | 0.030 |
Why?
|
Microcirculation | 2 | 2011 | 1278 | 0.030 |
Why?
|
MAP Kinase Signaling System | 1 | 2002 | 1484 | 0.030 |
Why?
|
Mesalamine | 1 | 1995 | 136 | 0.030 |
Why?
|
Maxilla | 1 | 1998 | 491 | 0.030 |
Why?
|
Embolization, Therapeutic | 1 | 2004 | 1413 | 0.030 |
Why?
|
Blood Coagulation | 1 | 2021 | 1157 | 0.030 |
Why?
|
Reproducibility of Results | 5 | 2014 | 20080 | 0.030 |
Why?
|
Aging | 2 | 2011 | 8651 | 0.030 |
Why?
|
Kinetics | 1 | 2002 | 6377 | 0.030 |
Why?
|
Radiography, Abdominal | 1 | 2017 | 532 | 0.030 |
Why?
|
Insulin | 1 | 2009 | 6597 | 0.030 |
Why?
|
Emigration and Immigration | 1 | 2017 | 395 | 0.030 |
Why?
|
Rehabilitation Centers | 1 | 2015 | 248 | 0.030 |
Why?
|
Angiography, Digital Subtraction | 1 | 1995 | 334 | 0.030 |
Why?
|
Nutritional Support | 1 | 1995 | 172 | 0.030 |
Why?
|
Rupture | 1 | 1995 | 443 | 0.030 |
Why?
|
Antidepressive Agents | 1 | 2006 | 2890 | 0.030 |
Why?
|
Biopsy | 2 | 2019 | 6771 | 0.030 |
Why?
|
Mitral Valve | 1 | 2022 | 1486 | 0.030 |
Why?
|
North America | 1 | 2017 | 1284 | 0.030 |
Why?
|
Evidence-Based Medicine | 1 | 2005 | 3696 | 0.030 |
Why?
|
Neurologic Examination | 2 | 2009 | 916 | 0.030 |
Why?
|
Suicide | 2 | 2002 | 1599 | 0.030 |
Why?
|
Suicide, Attempted | 1 | 2002 | 1378 | 0.030 |
Why?
|
Epilepsy | 1 | 2008 | 3267 | 0.030 |
Why?
|
Calibration | 1 | 2015 | 816 | 0.030 |
Why?
|
Patient Discharge | 2 | 2016 | 3476 | 0.030 |
Why?
|
Peptic Ulcer | 1 | 2014 | 219 | 0.030 |
Why?
|
Algorithms | 3 | 2009 | 13981 | 0.030 |
Why?
|
Nerve Fibers, Myelinated | 2 | 2009 | 952 | 0.030 |
Why?
|
Dysarthria | 1 | 2012 | 58 | 0.030 |
Why?
|
Electroencephalography | 1 | 2008 | 6189 | 0.030 |
Why?
|
Incidence | 4 | 2017 | 21392 | 0.020 |
Why?
|
Radiography | 2 | 2013 | 6965 | 0.020 |
Why?
|
Wounds and Injuries | 1 | 2004 | 2477 | 0.020 |
Why?
|
Spleen | 1 | 2017 | 2298 | 0.020 |
Why?
|
Developing Countries | 2 | 2008 | 2868 | 0.020 |
Why?
|
Brain Mapping | 1 | 2006 | 6568 | 0.020 |
Why?
|
Abdominal Pain | 1 | 2017 | 1063 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2002 | 3106 | 0.020 |
Why?
|
Water | 2 | 2011 | 1407 | 0.020 |
Why?
|
Veins | 1 | 1995 | 765 | 0.020 |
Why?
|
Hand Strength | 1 | 2014 | 452 | 0.020 |
Why?
|
Child, Preschool | 4 | 2008 | 42063 | 0.020 |
Why?
|
Neck | 1 | 1995 | 731 | 0.020 |
Why?
|
Emigrants and Immigrants | 1 | 2017 | 539 | 0.020 |
Why?
|
Age Factors | 3 | 2015 | 18416 | 0.020 |
Why?
|
Anisotropy | 1 | 2014 | 1278 | 0.020 |
Why?
|
Ataxia | 1 | 2012 | 305 | 0.020 |
Why?
|
Steroids | 1 | 1995 | 928 | 0.020 |
Why?
|
Europe | 1 | 2017 | 3441 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2021 | 2622 | 0.020 |
Why?
|
Practice Guidelines as Topic | 1 | 2007 | 7475 | 0.020 |
Why?
|
Random Allocation | 1 | 2014 | 2394 | 0.020 |
Why?
|
Echocardiography | 1 | 2002 | 4981 | 0.020 |
Why?
|
Rats, Inbred SHR | 1 | 2009 | 186 | 0.020 |
Why?
|
Hepatitis C | 1 | 1999 | 1579 | 0.020 |
Why?
|
Nerve Tissue Proteins | 1 | 2002 | 4407 | 0.020 |
Why?
|
Brain Damage, Chronic | 1 | 2010 | 267 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2021 | 8552 | 0.020 |
Why?
|
Survival Analysis | 1 | 2021 | 10182 | 0.020 |
Why?
|
Critical Illness | 1 | 2021 | 2709 | 0.020 |
Why?
|
Perfusion Imaging | 1 | 2010 | 196 | 0.020 |
Why?
|
Anemia | 1 | 2017 | 1511 | 0.020 |
Why?
|
Neuroradiography | 1 | 2008 | 71 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2020 | 10827 | 0.020 |
Why?
|
Disopyramide | 1 | 1987 | 16 | 0.020 |
Why?
|
Hospitals, University | 1 | 2010 | 568 | 0.020 |
Why?
|
Basal Ganglia | 1 | 2011 | 552 | 0.020 |
Why?
|
Liver Transplantation | 1 | 1999 | 2325 | 0.020 |
Why?
|
Radioligand Assay | 1 | 1988 | 366 | 0.020 |
Why?
|
Infant | 2 | 2008 | 36060 | 0.020 |
Why?
|
Brain Neoplasms | 1 | 2008 | 8986 | 0.020 |
Why?
|
Iopamidol | 1 | 2007 | 186 | 0.020 |
Why?
|
Osmolar Concentration | 1 | 1988 | 660 | 0.020 |
Why?
|
Models, Statistical | 2 | 2014 | 5075 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2010 | 1578 | 0.020 |
Why?
|
Anemia, Sickle Cell | 1 | 1994 | 1056 | 0.020 |
Why?
|
Gonadal Steroid Hormones | 1 | 2010 | 701 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 1 | 1995 | 1796 | 0.020 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2009 | 791 | 0.020 |
Why?
|
Cross-Sectional Studies | 3 | 2015 | 25942 | 0.020 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2011 | 1112 | 0.020 |
Why?
|
Blood Pressure | 1 | 2020 | 8525 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2007 | 15697 | 0.010 |
Why?
|
Liver | 1 | 2000 | 7509 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2007 | 13630 | 0.010 |
Why?
|
Liver Cirrhosis | 1 | 2014 | 1931 | 0.010 |
Why?
|
Atmospheric Pressure | 1 | 2003 | 46 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2015 | 3562 | 0.010 |
Why?
|
Ontario | 1 | 2004 | 404 | 0.010 |
Why?
|
Hand | 1 | 2009 | 903 | 0.010 |
Why?
|
Patient Education as Topic | 1 | 2013 | 2315 | 0.010 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2005 | 461 | 0.010 |
Why?
|
Forelimb | 1 | 2003 | 115 | 0.010 |
Why?
|
Neurons | 1 | 2002 | 9426 | 0.010 |
Why?
|
Health Status | 1 | 2015 | 4081 | 0.010 |
Why?
|
Amyloidosis | 1 | 2008 | 817 | 0.010 |
Why?
|
Terminology as Topic | 1 | 2008 | 1535 | 0.010 |
Why?
|
Hypercapnia | 1 | 2003 | 261 | 0.010 |
Why?
|
Data Collection | 1 | 2010 | 3315 | 0.010 |
Why?
|
Injury Severity Score | 1 | 2004 | 1033 | 0.010 |
Why?
|
Models, Neurological | 1 | 2009 | 1758 | 0.010 |
Why?
|
Sex Characteristics | 1 | 2011 | 2629 | 0.010 |
Why?
|
Chloramphenicol O-Acetyltransferase | 1 | 2000 | 221 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2006 | 2362 | 0.010 |
Why?
|
Sample Size | 1 | 2003 | 840 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2017 | 5325 | 0.010 |
Why?
|
ROC Curve | 1 | 2007 | 3568 | 0.010 |
Why?
|
Probability | 1 | 2004 | 2475 | 0.010 |
Why?
|
Pain | 1 | 1994 | 5066 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2009 | 2696 | 0.010 |
Why?
|
Trauma Centers | 1 | 2004 | 933 | 0.010 |
Why?
|
Flavonoids | 1 | 2002 | 445 | 0.010 |
Why?
|
Anticonvulsants | 1 | 2008 | 1879 | 0.010 |
Why?
|
Safety | 1 | 2003 | 1148 | 0.010 |
Why?
|
Organ Size | 1 | 2003 | 2254 | 0.010 |
Why?
|
Neural Pathways | 1 | 2009 | 3040 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2011 | 11071 | 0.010 |
Why?
|
Clinical Competence | 1 | 2013 | 4783 | 0.010 |
Why?
|
Medicare | 1 | 2015 | 6786 | 0.010 |
Why?
|
Linear Models | 1 | 2007 | 5877 | 0.010 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2011 | 3455 | 0.010 |
Why?
|
Urban Population | 1 | 2004 | 2022 | 0.010 |
Why?
|
Imidazoles | 1 | 2002 | 1180 | 0.010 |
Why?
|
Cells, Cultured | 2 | 2002 | 18957 | 0.010 |
Why?
|
Plasmids | 1 | 2000 | 2275 | 0.010 |
Why?
|
Behavior, Animal | 1 | 2003 | 1866 | 0.010 |
Why?
|
Skinfold Thickness | 1 | 1994 | 158 | 0.010 |
Why?
|
Contrast Media | 1 | 2007 | 5305 | 0.010 |
Why?
|
Pharmaceutical Preparations | 1 | 2001 | 1091 | 0.010 |
Why?
|
Urination Disorders | 1 | 1994 | 240 | 0.010 |
Why?
|
Cardiovascular Diseases | 2 | 2010 | 15757 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2003 | 5201 | 0.010 |
Why?
|
Primary Health Care | 1 | 2008 | 4647 | 0.010 |
Why?
|
Cell Survival | 1 | 2002 | 5797 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2002 | 3726 | 0.010 |
Why?
|
Menstrual Cycle | 1 | 1994 | 536 | 0.010 |
Why?
|
Cold Temperature | 1 | 1994 | 780 | 0.010 |
Why?
|
Bone Diseases | 1 | 1994 | 419 | 0.010 |
Why?
|
Cough | 1 | 1994 | 595 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2008 | 26181 | 0.000 |
Why?
|
Amino Acid Sequence | 1 | 2000 | 13451 | 0.000 |
Why?
|
Chi-Square Distribution | 1 | 1994 | 3465 | 0.000 |
Why?
|
Research Design | 1 | 2003 | 6180 | 0.000 |
Why?
|
Molecular Sequence Data | 1 | 2000 | 17624 | 0.000 |
Why?
|
Gene Expression | 1 | 2000 | 7588 | 0.000 |
Why?
|
Fever | 1 | 1994 | 1617 | 0.000 |
Why?
|
Tachycardia | 1 | 1987 | 602 | 0.000 |
Why?
|
Pulmonary Edema | 1 | 1987 | 409 | 0.000 |
Why?
|
Mice | 2 | 2002 | 81208 | 0.000 |
Why?
|
Mice, Inbred C57BL | 1 | 2002 | 22023 | 0.000 |
Why?
|
Ambulatory Care | 1 | 1994 | 2781 | 0.000 |
Why?
|
Patient Acceptance of Health Care | 1 | 1994 | 3164 | 0.000 |
Why?
|